This review will discuss current research areas for therapeutic approaches for the treatment of T1D, and it will specifically compare the different ways in which β-cell transdifferentiation of non-insulin-producing cells through gene therapy can be initiated and maintained. This evidence concerns the gene INS and type 1 diabetes mellitus.